Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 31ASTRAZENECA

02 4GLAXOSMITHKLINE

03 4JANSSEN BIOTECH

04 9PHARMAAND

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
BioProcess International US West
Not Confirmed
arrow
BioProcess International US West
Not Confirmed

OLAPARIB

US Patent Number : 8143241

Drug Substance Claim :

Drug Product Claim :

Application Number : 208558

Patent Use Code : U-2833

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-08-12

blank

02

arrow
BioProcess International US West
Not Confirmed
arrow
BioProcess International US West
Not Confirmed

OLAPARIB

US Patent Number : 8143241

Drug Substance Claim :

Drug Product Claim :

Application Number : 208558

Patent Use Code : U-2820

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-08-12

blank

03

arrow
BioProcess International US West
Not Confirmed
arrow
BioProcess International US West
Not Confirmed

OLAPARIB

US Patent Number : 8143241

Drug Substance Claim :

Drug Product Claim :

Application Number : 208558

Patent Use Code : U-2482

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-08-12

blank

04

arrow
BioProcess International US West
Not Confirmed
arrow
BioProcess International US West
Not Confirmed

OLAPARIB

US Patent Number : 8143241

Drug Substance Claim :

Drug Product Claim :

Application Number : 208558

Patent Use Code : U-2821

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-08-12

blank

05

arrow
BioProcess International US West
Not Confirmed
arrow
BioProcess International US West
Not Confirmed

OLAPARIB

US Patent Number : 8143241

Drug Substance Claim :

Drug Product Claim :

Application Number : 208558

Patent Use Code : U-2819

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-08-12

blank

06

arrow
BioProcess International US West
Not Confirmed
arrow
BioProcess International US West
Not Confirmed

OLAPARIB

US Patent Number : 8143241

Drug Substance Claim :

Drug Product Claim :

Application Number : 206162

Patent Use Code : U-1634

Delist Requested :

Patent Use Description : TREATMENT OF BRCA MUTA...

Patent Expiration Date : 2027-08-12

blank

07

arrow
BioProcess International US West
Not Confirmed
arrow
BioProcess International US West
Not Confirmed

OLAPARIB

US Patent Number : 8143241

Drug Substance Claim :

Drug Product Claim :

Application Number : 208558

Patent Use Code : U-2716

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-08-12

blank

08

arrow
BioProcess International US West
Not Confirmed
arrow
BioProcess International US West
Not Confirmed

OLAPARIB

US Patent Number : 8143241

Drug Substance Claim :

Drug Product Claim :

Application Number : 208558

Patent Use Code : U-3631

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-08-12

blank

09

arrow
BioProcess International US West
Not Confirmed
arrow
BioProcess International US West
Not Confirmed

OLAPARIB

US Patent Number : 8143241

Drug Substance Claim :

Drug Product Claim :

Application Number : 208558

Patent Use Code : U-2716

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-08-12

blank

10

arrow
BioProcess International US West
Not Confirmed
arrow
BioProcess International US West
Not Confirmed

OLAPARIB

US Patent Number : 8143241

Drug Substance Claim :

Drug Product Claim :

Application Number : 208558

Patent Use Code : U-2824

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-08-12

blank